Atrial fibrillation (Afib) doesn’t look the same in everyone—and gender plays a big role. Women often experience Afib differently than men, reporting not just more frequent symptoms, but a wider mix of them. Instead of the classic heart-related signs, many women struggle with ongoing fatigue or a general feeling of weakness. Because these symptoms are less obvious, Afib in women is more likely to be overlooked or diagnosed later. This makes it especially important to understand how Afib shows up in women, so care and treatment can be better matched to their experiences.
Key insights
-
46% of Afib episodes in pregnant women occur within 24 hours after childbirth, highlighting a critical risk window.
-
25% of postmenopausal women are expected to develop Afib at some point in their lives.
-
Higher Afib incidence is seen in women with no children or more than 3–4 live births, indicating a U-shaped relationship between parity and Afib risk.
-
Women with Afib face a significantly higher risk of stroke and heart attack, especially if not prescribed anticoagulants, contributing to higher mortality rates compared to men.
What research tells us about women and Afib
Women with Afib often face a different and sometimes heavier health impact than men. They tend to experience more severe and intense Afib episodes and carry a higher risk of stroke. Symptoms can also appear differently in women, which can make the condition harder to recognize. Certain life stages, such as pregnancy and menopause, can further increase risk. Interestingly, research has also shown that Afib risk may rise with the number of pregnancies a woman has had. Together, these differences highlight why Afib should be understood and treated with women’s unique experiences in mind.
Greater Afib-related complications in women
Women with Afib often don’t just feel more severe symptoms—they also face a higher risk of serious complications. Their symptoms can be more intense and harder to manage, and many women live with the condition for longer periods of time. This is partly because Afib in women is more likely to be missed or diagnosed later, especially when symptoms are vague or mistaken for stress or fatigue. Combined with women’s longer life expectancy, this means Afib can have a greater impact on their daily lives over the years, leading to a lower overall quality of life if not properly recognized and treated.
Elevated risk of stroke and heart attack in women with Afib
Even though Afib is less common in women than in men, its effects are often more serious for women. Women with Afib have a higher risk of stroke, heart attacks, and life-threatening complications, which can lead to higher death rates. This risk is especially high for women who are not taking blood-thinning medication, as studies show a much stronger link between Afib and stroke in these cases.
Menopause and the growing risk of Afib
Age is one of the strongest risk factors for Afib, and the transition into menopause may further increase that risk. While research has not yet proven a direct cause-and-effect link between menopause and Afib, estimates suggest that around one in four postmenopausal women will develop the condition at some point in their lives.
Lifestyle also plays a big role in Afib risk. Stress, mental health, and diet all affect heart health, and women are often more sensitive to long-term stress. Conditions like depression and post-traumatic stress disorder (PTSD) are more common in women and are known to increase the risk of Afib. Research shows that postmenopausal women who live with high stress or have a history of mental health challenges are much more likely to develop Afib, highlighting how closely emotional well-being and heart health are connected.
Research suggests that women who go through menopause earlier in life may have a higher chance of developing Afib and having a stroke. One possible reason is that their bodies are exposed to estrogen and other female hormones for fewer years. These hormones help protect the heart, so when that protection ends earlier, the risk of heart problems like Afib may increase over time.
Afib and pregnancy: navigating risks and treatment
Pregnancy doesn’t usually cause Afib on its own, but it can make symptoms much worse for women who already have the condition. Research shows that the risk peaks late in pregnancy, especially during the third trimester. In fact, nearly half of Afib episodes related to pregnancy occur within the first 24 hours after childbirth, making the period around delivery a particularly vulnerable time.
Treatment during pregnancy is particularly challenging, as certain antiarrhythmic medications can pose serious risks to the fetus, especially at the end of the first trimester. For example, drugs like Atenolol and Amiodarone have been associated with fetal complications. Pregnant women with Afib should consult closely with their healthcare providers to balance maternal health with fetal safety.
Afib during pregnancy can also raise the risk of dangerous blood clots, known as thromboembolisms. This happens because the heart’s upper chambers don’t pump blood as effectively, allowing clots to form more easily. To lower this risk, doctors may recommend blood-thinning medications (anticoagulants) to help prevent clots and protect both the mother and baby.
Interestingly, research suggests that the number of children a woman has may be linked to their risk of developing Afib. Women with no children, as well as those who have had more than three or four births, appear to have a higher risk of Afib. This pattern hints that long-term hormonal or physical changes related to pregnancy and childbirth may play a role, though researchers are still working to fully understand why.
Treatment considerations: Why women need a personalized approach
Treatment for Afib doesn’t work the same way for everyone, and women often respond differently from men. Differences in hormones and body chemistry can affect how heart rhythm medications work, and women are more likely to experience side effects from these drugs. Factors such as body size, body fat, and how medications are absorbed also make finding the right dose more challenging.
Some heart medications, including certain cardiac glycosides, have even been linked to an increased risk of breast cancer, highlighting why a one-size-fits-all approach to treatment doesn’t work well for women. Personalized medication choices are especially important to ensure both safety and effectiveness.
Differences also appear in procedural treatments. Women are more likely to experience complications during catheter ablation procedures performed in the hospital, which may be partly due to anatomical factors such as a smaller average heart size.
How MyAfib can help
Because Afib often presents differently in women, recognizing your condition early is especially important. If you're noticing symptoms that might be Afib, or if Afib runs in your family, discussing your personal risk with a healthcare provider is a critical step. Understanding whether hormonal factors, life stage, stress, or family history may be playing a role can help guide your care.
To make the most of your appointment, consistent tracking is essential. Recording daily symptoms such as palpitations, fatigue, dizziness, or weakness helps reveal patterns that might otherwise be dismissed as stress or aging. Tracking lifestyle factors like stress levels and sleep quality can also reveal how these influences affect your Afib. Data from a smartwatch or portable ECG device provides additional objective information for your healthcare provider to review, especially valuable since women's Afib symptoms can be subtle or hard to pin down.
MyAfib is designed specifically for this purpose. As a dedicated Afib tracker, MyAfib allows you to log symptoms, heart rhythm readings, triggers, medications and lifestyle factors all in one place. By using MyAfib regularly, you create a clear, structured overview of your condition that you can easily share during appointments. This is particularly important for women, since comprehensive records help ensure your symptoms are taken seriously and not overlooked.
If you feel your concerns are not being fully addressed, or if you suspect your Afib has been missed or misdiagnosed, having detailed records in MyAfib can strengthen your conversations and help you advocate for appropriate follow-up.
